This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunocore Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Emma Grant: Innovator in Binding Molecules
Introduction
Emma Grant is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that have the potential to revolutionize treatments for malignant diseases.
Latest Patents
Emma holds a patent for her invention titled "Binding Molecules." This innovative patent relates to binding molecules that comprise T cell receptor (TCR) variable domains, which can bind to a PIWIL1 peptide-HLA complex. The implications of this invention are profound, as it opens new avenues for the treatment of various malignant diseases.
Career Highlights
Emma Grant is currently associated with Immunocore Limited, a company known for its cutting-edge research in immunotherapy. Her work at Immunocore has positioned her as a key player in the advancement of therapeutic solutions that harness the body's immune system to fight cancer.
Collaborations
Emma collaborates with talented individuals such as Nicole Mai and Arnaud Techine. These partnerships enhance the innovative environment at Immunocore and contribute to the success of their research initiatives.
Conclusion
Emma Grant's work in binding molecules exemplifies the impact of innovative thinking in the field of biotechnology. Her contributions are paving the way for new treatments that could significantly improve patient outcomes in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile